AN OPEN LABEL, RANDOMISED, PHASE II STUDY OF AS1404 IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN EPITHELIAL CANCER

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004375-11

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The overall aim of this study is to determine whether AS1404 will increase efficacy of carboplatin and paclitaxel combination in treating patients with platinum-sensitive recurrent ovarian epithelial cancer.


Critère d'inclusion

  • Platinum Sensitive Recurrent Ovarian Epithelial Cancer